LAS41008 in Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the efficacy and safety of LAS41008 in comparison to
active control and placebo in patients with moderate to severe chronic plaque psoriasis